mcr-1 in multidrug-resistant blaKPC-2-producing clinical Enterobacteriaceae isolates in Singapore

Antimicrobial Agents and Chemotherapy

Volumn 60, Issue 10, 2016, Pages 6435-6437

  Teo, Jocelyn Qi Min ^a   Ong, Rick Twee Hee ^b   Xia, Eryu ^c   Koh, Tse Hsien ^a   Khor, Chiea Chuen ^d   Lee, Shannon Jing Yi ^a   Lim, Tze Peng ^a,e   Kwa, Andrea Lay Hoon ^a,e,f  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d GENOME INSTITUTE OF SINGAPORE   (Singapore)

^e DUKE NUS MEDICAL SCHOOL   (Singapore)

^f NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

POLYMYXIN B; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; POLYMYXIN;

ANTIBIOTIC RESISTANCE; BACTERIAL GENE; BACTERIUM ISOLATE; BLA KPC 2 GENE; CONJUGATION; ENTEROBACTER AEROGENES; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GENE ACTIVITY; GENETIC HETEROGENEITY; LETTER; MCR 1 GENE; NONHUMAN; PLASMID; PRIORITY JOURNAL; SINGAPORE; SINGLE NUCLEOTIDE POLYMORPHISM; BACTERIAL GENOME; DNA SEQUENCE; DRUG EFFECTS; ENTEROBACTERIACEAE INFECTION; ENZYMOLOGY; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; GENOME, BACTERIAL; HUMANS; PLASMIDS; POLYMYXINS; SEQUENCE ANALYSIS, DNA; SINGAPORE;

EID: 84992401687     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00804-16     Document Type: Letter

References (14)

1. Hsu LY, Tan TY, Tam VH, Kwa A, Fisher DA, Koh TH, Network for Antimicrobial Resistance Surveillance. 2010. Surveillance and correlation of antibiotic prescription and resistance of Gram-negative bacteria in Singaporean hospitals. Antimicrob Agents Chemother 54:1173-1178. http://dx.doi.org/10.1128/AAC.01076-09.
2. Teo J, Cai Y, Lim TP, Tan TT, Kwa AL. 2016. Carbapenem resistance in gram-negative bacteria: the not-so-little problem in the little red dot. Microorganisms 4:13. http://dx.doi.org/10.3390/microorganisms4010013.
3. Clinical and Laboratory Standards Institute. 2016. Performance standards for antimicrobial susceptibility testing, 26th ed. CLSI supplement M100S. Clinical and Laboratory Standards Institute, Wayne, PA.
4. Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J, Doi Y, Tian G, Dong B, Huang X, Yu LF, Gu D, Ren H, Chen X, Lv L, He D, Zhou H, Liang Z, Liu JH, Shen J. 2016. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 16:161-168. http://dx.doi.org/10.1016/S1473-3099(15)00424-7.
5. Li A, Yang Y, Miao M, Chavda KD, Mediavilla JR, Xie X, Feng P, Tang YW, Kreiswirth BN, Chen L, Du H. 2016. Complete sequences of mcr-1-harboring plasmids from extended-spectrum-beta-lactamase- and carbapenemase-producing Enterobacteriaceae. Antimicrob Agents Chemother 60:4351-4354. http://dx.doi.org/10.1128/AAC.00550-16.
6. Ye H, Li Y, Li Z, Gao R, Zhang H, Wen R, Gao GF, Hu Q, Feng Y. 2016. Diversified mcr-1-harboring plasmid reservoirs confer resistance to colistin in human gut microbiota. mBio 7:e00177-16. http://dx.doi.org/10.1128/mBio.00177-16.
7. Wirth T, Falush D, Lan R, Colles F, Mensa P, Wieler LH, Karch H, Reeves PR, Maiden MC, Ochman H, Achtman M. 2006. Sex and virulence in Escherichia coli: an evolutionary perspective. Mol Microbiol 60:1136-1151. http://dx.doi.org/10.1111/j.1365-2958.2006.05172.x.
8. Mulvey MR, Mataseje LF, Robertson J, Nash JH, Boerlin P, Toye B, Irwin R, Melano RG. 2016. Dissemination of the mcr-1 colistin resistance gene. Lancet Infect Dis 16:289-290. http://dx.doi.org/10.1016/S1473-3099(16)00067-0.
9. Poirel L, Kieffer N, Brink A, Coetze J, Jayol A, Nordmann P. 2016. Genetic features of MCR-1-producing colistin-resistant Escherichia coli isolates in South Africa. Antimicrob Agents Chemother 60:4394-4397. http://dx.doi.org/10.1128/AAC.00444-16.
10. Falgenhauer L, Waezsada SE, Yao Y, Imirzalioglu C, Kasbohrer A, Roesler U, Michael GB, Schwarz S, Werner G, Kreienbrock L, Chakraborty T, RESET Consortium. 2016. Colistin resistance gene mcr-1 in extended-spectrum beta-lactamase-producing and carbapenemase-producing Gram-negative bacteria in Germany. Lancet Infect Dis 16:282-283. http://dx.doi.org/10.1016/S1473-3099(16)00009-8.
11. Du H, Chen L, Tang YW, Kreiswirth BN. 2016. Emergence of the mcr-1 colistin resistance gene in carbapenem-resistant Enterobacteriaceae. Lancet Infect Dis 16:287-288. http://dx.doi.org/10.1016/S1473-3099(16)00056-6.
12. Poirel L, Kieffer N, Liassine N, Thanh D, Nordmann P. 2016. Plasmid-mediated carbapenem and colistin resistance in a clinical isolate of Escherichia coli. Lancet Infect Dis 16:281. http://dx.doi.org/10.1016/S1473-3099(16)00006-2.
13. NDM-1 in Escherichia coli from Venezuela. Antimicrob Agents Chemother http://dx.doi.org/10.1128/AAC.01319-16.
14. Yao X, Doi Y, Zeng L, Lv L, Liu JH. 2016. Carbapenem-resistant and colistin-resistant Escherichia coli co-producing NDM-9 and MCR-1. Lancet Infect Dis 16:288-289. http://dx.doi.org/10.1016/S1473-3099(16)00057-8.